Pliant Therapeutics saw the highest growth of 0.99% in patent filings in May and 1.49% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.66% and grants by 0.66%. GlobalData’s DataBook provides a comprehensive analysis of Pliant Therapeutics’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Pliant Therapeutics has been focused on protecting inventions in United States(US) with three publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 20% filings and 29% grants. The United States(US), Australia(AU), Israel(IL), and Chile(CL) patent Office are among the top ten patent offices where Pliant Therapeutics is filings its patents. Among the top granted patent authorities, Pliant Therapeutics has 29% of its grants in United States(US), 14% in Australia(AU) and 14% in Israel(IL).
Bayer and Gilead Sciences could be the strongest competitors for Pliant Therapeutics
In terms of grant share, Pliant Therapeutics stands in tenth position among its competitors. Bayer and Gilead Sciences secured the top positions according to recent patent publication data.
Patents related to rare diseases lead Pliant Therapeutics's portfolio
Pliant Therapeutics has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and 100% of patents were granted in Q2 2024.
Idiopathic pulmonary fibrosis related patents lead Pliant Therapeutics portfolio followed by fibrosis, and pneumonia
Pliant Therapeutics has highest number of patents in idiopathic pulmonary fibrosis followed by fibrosis, pneumonia, lung disease, and biliary atresia. For idiopathic pulmonary fibrosis, nearly 28% of patents were filed and 13% of patents were granted in Q2 2024.
For comprehensive analysis of Pliant Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
